Accreditation and Disclosure
World Class CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
World Class CME designates this live activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Board of Radiology Maintenance of Certification – 20 AMA PRA Category 1 Credits™ – AMA credits can be used toward ABR MOC Part 2 requirements.
SAM credits can be used ABR MOC Part 2 SA-CME requirements.
Physician Assistants (PA) – The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. This course qualifies for Category 1 CME for PAs.
Nurse Practitioners and RNs – The American Nurses Credentialing Center and the American Academy of Nurse Practitioners Certification Program accept continuing education credits sponsored by organizations, agencies, or educational institutions accredited or approved by the Accreditation Council for Continuing Medical Education (ACCME).
Category A CE credit has been approved by the American Society of Radiologic Technologists. The American Registry of Diagnostic Medical Sonographers (ARDMS) accepts all American Society of Radiologic Technologists (ASRT) Category A credits as fulfilling their requirements for continuing education (CE) credits.
Breast Ultrasound with Tom Stavros 2019 1/18/2019 AM Session 4.75 CE Credits
Breast Ultrasound with Tom Stavros 2019 1/18/2019 PM Session 4.25 CE Credits
Breast Ultrasound with Tom Stavros 2019 1/19/2019 AM Session 5 CE Credits
Breast Ultrasound with Tom Stavros 2019 1/19/2019 PM Session 4.25 CE Credits
Breast Ultrasound with Tom Stavros 2019 1/20/2019 AM Session 5.25 CE Credits
World Class CME relies on its CME faculty to provide program content that is evidence based and free of commercial bias. Therefore, in accordance with ACCME standards, any faculty, program director, reviewer, and/or provider industry relationships will be disclosed and resolved. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.